An updated analysis of opioids increasing the risk of fractures
Open accessPublished version of a preprint
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the relationship between opioid therapy for chronic noncancer pain and fracture risk by a meta-analysis of cohort studies and case-control studies. METHODS: The included cohort studies and case-control studies were identified by searching the PubMed and EMBASE databases from their inception until May 24, 2019. The outcome of interest was a fracture. This information was independently screened by two authors. When the heterogeneity among studies was significant, a random effects model was used to determine the overall combined risk estimate. RESULTS: In total, 12 cohort studies and 6 case-control studies were included. We used the Newcastle-Ottawa Scale (NOS) to evaluate the quality of the included literature, and 14 of the studies were considered high-quality studies. The overall relative risk of opioid therapy and fractures was 1.78 (95% confidence interval (CI) 1.53-2.07). Subgroup analyses revealed sources of heterogeneity, sensitivity analysis was stable, and no publication bias was observed. CONCLUSIONS: The meta-analysis showed that the use of opioids significantly increased the risk of fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“major osteoporotic fractures (246, 248) in opioid-treated patients.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [248]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Use of exogenous opioids has been associated with an increased risk of fractures in several meta-analyses (245-248).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [248]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“The fixed effects model was applied when I(2) <50% [15], otherwise, the random effects model was applied [16]; to further explore the source of heterogeneity, we also examined the study design, the study area and subfamily analysis of fracture types (i.”
Method(2014) · Medical Entomology and Zoology · Cited by 17,633
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267
Guidance on the management of pain in older people
(2013) · Age and Ageing · doi:10.1093/ageing/afs200 · Cited by 727 · cited 1×
“Pain is a common symptom in the elderly population, and the incidence of chronic pain ranges from 25% to 76% [1].”
BackgroundCentral Nervous System–Active Medications and Risk for Falls in Older Women
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., Bauer, D. C., Schwartz, A. V., Hanlon, J. T., Nevitt, M. C., & For The Study of Osteoporotic Fractures Research Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50453.x · Cited by 620
The Comparative Safety of Analgesics in Older Adults With Arthritis
Solomon, D. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.391 · Cited by 416 · cited 1×
“One mechanism is that opioids may reduce bone density by inhibiting the production of endogenous sex hormones, leading to an increased risk of fractures [34]; the other mechanism involves the side effects of opioids, such as the central nervous system side effects of vertigo, fatigue, etc.”
BackgroundCentral Nervous System Active Medications and Risk for Fractures in Older Women
Ensrud, K. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.949 · Cited by 277 · cited 2×
“Based on a regional subgroup analysis, we found that the research conducted in Canada and the United States made an important contribution to the heterogeneity (Fig 5).”
BackgroundRelationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients
Saunders, K. W., Dunn, K. M., Merrill, J. O., Sullivan, M., Weisner, C., Braden, J. B., Psaty, B. M., & Von Korff, M. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1218-z · Cited by 271
Fracture risk associated with the use of morphine and opiates
VESTERGAARD, P., REJNMARK, L., & MOSEKILDE, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01667.x · Cited by 244
Cited by
Agarwal, P., Saha, S., & Hariprasad, P. (2021) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-021-01998-6 · Cited by 92
KotliÅ„ska-Lemieszek, A., & Zylicz, Z. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s342409 · Cited by 74
“that in patients treated for pain with opioids, the overall risk of fractures increased by about 80%.(22) The higher risk”
Chin, N. A., Salihah, N. T., Shivanand, P., & Ahmed, M. U. (2021) · Journal of Food Science and Technology · doi:10.1007/s13197-021-05280-5 · Cited by 48
Shah, R., Raji, M. A., Westra, J. R., & Kuo, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052057 · Cited by 28
Endogenous opiates and behavior: 2020
Bodnar, R. J. (2022) · Peptides · doi:10.1016/j.peptides.2022.170752 · Cited by 28
Review of publications evaluating opioid use in patients with inflammatory rheumatic disease
Anastasiou, C., & Yazdany, J. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000868 · Cited by 23
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Fisher, L., Fisher, A., & Smith, P. N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103253 · Cited by 20
Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements
da Costa, N. D. S., Lima, L. S., Galiciolli, M. E. A., Ribeiro, D. H. F., Ribeiro, M. M., Garica, G. D. P. J., Marçal, I. S., da Silva, J. F., Pereira, M. E., Oliveira, C. S., et al. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127446 · Cited by 15
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Khan, N. F., Bykov, K., Katz, J. N., Glynn, R. J., Vine, S. M., & Kim, S. C. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5773 · Cited by 12
Figueroa‐Parra, G., Jeffery, M. M., Dabit, J. Y., Chevet, B., Valenzuela-Almada, M. O., Hocaoǧlu, M., Osei‐Onomah, S., Kurani, S. S., Vallejo, S., Achenbach, S. J., et al. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.220822 · Cited by 12
“25 FM and depression have been previously associated with higher use of opioid therapy in the general population.”
BackgroundProblems with opioids - beyond misuse
Kheirabadi, D., Minhas, D., Ghaderpanah, R., & Clauw, D. J. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101935 · Cited by 11
The opioid epidemic from the acute care hospital front line
Macintyre, P. E. (2021) · Anaesthesia and Intensive Care · doi:10.1177/0310057x211018211 · Cited by 10
Obekpa, E. O., McCurdy, S., Gallardo, K. R., Rodriguez, S. A., Cazaban, C. G., Brown, H. S., Yang, J. J., & Wilkerson, J. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1412934 · Cited by 9
Kafel, H., Braga‐Basaria, M., & Basaria, S. S. (2025) · Andrology · doi:10.1111/andr.70013 · Cited by 8
Honda, H., Ashizawa, R., Kameyama, Y., Hirase, T., Arizono, S., & Yoshimoto, Y. (2024) · European Geriatric Medicine · doi:10.1007/s41999-024-00965-4 · Cited by 7
The cost of opioid use disorder-related conditions in Medicare
Mark, T. L., Parish, W. J., Weber, E. M., Steinberg, D. G., & Henretty, K. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109778 · Cited by 7
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology
Puri, C., Dannenberg, C., Ucci, A., Ponzetti, M., Pucci, E., Silvestri, L., Lau, P., Frings‐Meuthen, P., Heer, M. A., Rucci, N., et al. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01199-z · Cited by 5
“Finally, different studies have shown that the chronic use of opioids can lead to decreased bone density and increased risk of fractures [41, 42].”
BackgroundMelsen, I. M., Szépligeti, S. K., Gundtoft, P. H., & Pedersen, A. B. (2024) · European Journal of Pain · doi:10.1002/ejp.2271 · Cited by 4
“Further, chronic opioid use increases the risk of falls, new fractures and mortality (Yue et al., 2020).”
Risbo, N., Ehrenstein, V., Gundtoft, P. H., Gjertsen, J., & Pedersen, A. B. (2025) · European Journal of Pain · doi:10.1002/ejp.70063 · Cited by 3
“Opioid use in the elderly increases the risks of respiratory depression, dizziness and postoperative delirium (Benyamin et al. 2008), as well as risks of falls, fractures (Yue et al. 2020) and mortality (Stone et al. 2023).”
Assessing the Relationship between Opioid Therapy and Osteoporosis
Ali, K., Blake, N., & Ahmed, N. (2024) · International journal of Pain · doi:10.56718/ijp.24-015 · Cited by 3
Fracture risk and opioid use in patients aged 17–64 years: An analysis of administrative claims data
Davis, J. W., Casteel, C. H., Brown, G., & Carnahan, R. M. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2849 · Cited by 3
Age disparities in adverse reactions of drugs used in pain therapies in Switzerland
Gasparovic, L., Burden, A. M., Senn, O., Markun, S., Quednow, B. B., Neuner‐Jehle, S., Stammschulte, T., & Weiler, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-28959-7 · Cited by 2
“In the present study, the median number of reported drugs per patient was higher in older adults (median 5 [range 1–35]) compared with younger adults (18–74 years; median 3 [range 1–42]).”
Metzger, C. E., Grecco, G. G., Tak, L. Y., Atwood, B. K., & Allen, M. R. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01239-8 · Cited by 2
“In the general population, opioid use has been associated with increased fracture risk [14–16].”
BackgroundKotlińska–Lemieszek, A. (2022) · Medycyna Paliatywna · doi:10.5114/pm.2022.126738 · Cited by 2
Association of morphine vs. fentanyl prescription dispensation with adverse clinical outcomes
Reyes, C., Pou, M. A., Díaz‐Torné, C., Carbonell-Abella, C., Brotons, C., & Martínez-Laguna, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1579634 · Cited by 2
Vertebroplastia percutánea en fracturas vertebrales osteoporóticas
Valle, J. B. D., Galich, F. M., Borensztein, M. A., & Petracchi, M. G. (2022) · Actualizaciones en osteología · Cited by 2
Understanding the Barriers to Effective Bone Health Management in People With Multiple Sclerosis
Grech, L., Jayanata, L. A., Caswell, N., Ohman, L. E., Reece, A., Allan, M., Butler, E. G., Ebeling, P. R., & Zengin, A. (2025) · International Journal of MS Care · doi:10.7224/1537-2073.2024-073 · Cited by 1
Tudorache, Y. M., Jensen, Sheehan, K. J., Gjertsen, J., & Pedersen, A. B. (2026) · European Journal of Pain · doi:10.1002/ejp.70280 · Cited by 1
“Opioid usage increases the risk of falls, which can lead to subsequent fractures (Yue et al. 2020) and elevated mortality (Lindestrand et al. 2015).”
Potentially Preventable Hospital Admissions Related to Medication: Stable, but shifting
Saïd, F. L. (2023) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.763376588 · Cited by 1
Bone Fractures in Patients Using Tapentadol or Oxycodone: An Exploratory US Claims Database Study
Morlion, B. J., Margarit, C., Wild, I., Karra, R., Liedgens, H., Sohns, M., & Finco, G. (2020) · Pain Management · doi:10.2217/pmt-2020-0065
Calidad de vida en cirugía compleja de columna
Suarez-Huerta, M. L. (2023) · Buleria (Universidad de León) · doi:10.18002/10612/16705
Analgesia for Orthopedic Fracture Surgery
Badaoui, J., Lirk, P. B., & Bains, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-80825-8_6
Opioid-induced Endocrinopathies - A Narrative Review
Khalil, A., & Kalhan, A. (2025) · Academic Medicine & Surgery · doi:10.62186/001c.147430
Characteristics of Pain Medication Use among Patients
Marcinkevičiūtė, A. (2025) · Lithuanian University of Health Sciences
Gudeti, B., Rao, A. R., Dey, A. B., Malhotra, R., Chakrawarty, A., & Chatterjee, P. (2026) · Journal of The Indian Academy of Geriatrics · doi:10.4103/jiag.jiag_25_25
Identificazione di nuove molecole coinvolte nell'omeostasi degli osteoblasti
Puri, C. (n.d.) · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
Rajha, H. E., Abugharbieh, L., Talhami, M., Alkeilani, O., Ghori, S. I., & Tayeh, A. E. (2026) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2026.104918
Metadata
- Authors
- Yue, Q., Ma, Y., Teng, Y., Zhu, Y., Liu, H., Xu, S., Liu, J., Liu, J., Zhang, X., & Teng, Z.
- Affiliations
- Kunming Medical University (CN)
- Second People's Hospital of Yunnan Province (CN)
- Corresponding author
- Zhang, Xiguang
- Teng, Zhaowei
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-04-09
- Volume
- 15
- Issue
- 4
- Pages
- e0220216
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7145014
- OpenAlex
- W3015229769
- Cited by
- 32
- References
- 38
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 2
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (81660156, 81860167)
- Joint special fund of Applied Fundamental Research of Kunming Medical University granted by Science and Technology Office of Yunnan (2018FE001(-175), 2018FE001(-174), 2014FZ048, 2017FE468(-181))
- Yunnan Special Funds for training high-level health and family planning technical personnel (H-2017064, H-2017028)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- opioids, fracture risk, chronic non-cancer pain, opioid therapy, bone fragility, adverse drug reactions
- MeSH terms
- Analgesics, Opioid, Humans, Risk, Cohort Studies, Case-Control Studies, Fractures, Bone, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.